Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12
- Ji Hyun Park
- , Sang Hoon Chun
- , Yun Gyoo Lee
- , Hyun Chang
- , Keun Wook Lee
- , Hye Ryun Kim
- , Seong Hoon Shin
- , Ho Jung An
- , Kyoung Eun Lee
- , In Gyu Hwang
- , Myung Ju Ahn
- , Sung Bae Kim
- , Bhumsuk Keam
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations